Ekso bionics announces $10 million bought deal offering of common stock

Richmond, calif., feb. 08, 2021 (globe newswire) -- ekso bionics holdings, inc. (nasdaq: ekso) (“ekso bionics”), an industry leader in exoskeleton technology for medical and industrial use, today announced that it has entered into an underwriting agreement with h.c. wainwright & co., llc under which the underwriter has agreed to purchase on a firm commitment basis 975,610 shares of common stock of ekso bionics, at a price to the public of $10.25 per share, less underwriting discounts and commissions. the closing of the offering is expected to occur on or about february 11, 2021, subject to the satisfaction of customary closing conditions.
EKSO Ratings Summary
EKSO Quant Ranking